Pharmaceutical News and Articles

Parental Support Package Reduces Burnout in Physicians in Training

A parental support package can significantly mitigate postpartum burnout among childbearing physicians in training, according to a study published online May 13

Worse Self-Rated Health Seen for Adults With Poor Mental Health Worldwide

Adults with poor mental health report worse self-rated overall health and more chronic illness, according to a study published online May 5 in PLOS Medicine. Ma

Parents' Antidepressant Use Not Linked to Neurodevelopmental Disorders in Offspring

Antidepressant use during pregnancy does not cause an increased risk for neurodevelopmental disorders in offspring, according to a review published in the June

American Aid Worker Tests Positive for Ebola After DRC Exposure

TUESDAY, May 19, 2026 An American doctor who was exposed to Ebola while working in the Democratic Republic of the Congo (DRC) has tested positive for the diseas

Fasenra Approved in US for Hypereosinophilic Syndrome

Enhertu Approved in the US for Two New Indications for Patients with HER2 Positive Early Breast Cancer

FDA Approves Immgolis Intri (golimumab-sldi), an Interchangeable Biosimilar to Simponi Aria (golimumab)

Researchers Identify First Suite of Human Antibodies Against Measles Virus

A scientific team funded by the National Institutes of Health (NIH) has isolated and mapped in detail the first comprehensive group of human antibodies targetin

Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease

Biogen Inc. (Nasdaq BIIB) today announced compelling topline results from the Phase 2 CELIA study evaluating diranersen (BIIB080), an investigational antisense

Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma

Regeneron Pharmaceuticals, Inc. (NASDAQ REGN) today reviewed results from the Phase 3 trial evaluating two dose levels of fianlimab (LAG-3 inhibitor) in combina